https://www.selleckchem.com/pr....oducts/tegatrabetan.
These changes in bile acid composition were associated with minor differences in the faecal microbiota in patients treated with elobixibat compared to placebo. Elobixibat appears to be safe. The only adverse effects of note are associated with its pharmacological actions in patients with chronic constipation,namely the induction of diarrhoea and abdominal pain. This new class of compound appears to be safe and efficacious in the treatment of chronic constipation. This new class of compound appears to be safe and efficacious in the